Elisabeth Kaiser1, Qinghai Tian1, Michael Wagner1, Monika Barth1, Wenying Xian1, Laura Schröder1, Sandra Ruppenthal1, Lars Kaestner1, Ulrich Boehm2, Philipp Wartenberg2, Huiyan Lu3, Sara M McMillin4, Derek B J Bone4, Jürgen Wess4, Peter Lipp1. 1. Center for Molecular Signaling (PZMS), Institute for Molecular Cell Biology; Medical Faculty, Saarland University, Homburg, Germany. 2. Center for Molecular Signaling (PZMS), Institute for Experimental and Clinical Pharmacology and Toxicology, Medical Faculty, Saarland University, Homburg, Germany. 3. Mouse Transgenic Core Facility, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA. 4. Molecular Signaling Section, Lab. of Bioorganic Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA.
Abstract
AIMS: Signalling via Gq-coupled receptors is of profound importance in many cardiac diseases such as hypertrophy and arrhythmia. Nevertheless, owing to their widespread expression and the inability to selectively stimulate such receptors in vivo, their relevance for cardiac function is not well understood. We here use DREADD technology to understand the role of Gq-coupled signalling in vivo in cardiac function. METHODS AND RESULTS: We generated a novel transgenic mouse line that expresses a Gq-coupled DREADD (Dq) in striated muscle under the control of the muscle creatine kinase promotor. In vivo injection of the DREADD agonist clozapine-N-oxide (CNO) resulted in a dose-dependent, rapid mortality of the animals. In vivo electrocardiogram data revealed severe cardiac arrhythmias including lack of P waves, atrioventricular block, and ventricular tachycardia. Following Dq activation, electrophysiological malfunction of the heart could be recapitulated in the isolated heart ex vivo. Individual ventricular and atrial myocytes displayed a positive inotropic response and arrhythmogenic events in the absence of altered action potentials. Ventricular tissue sections revealed a strong co-localization of Dq with the principal cardiac connexin CX43. Western blot analysis with phosphor-specific antibodies revealed strong phosphorylation of a PKC-dependent CX43 phosphorylation site following CNO application in vivo. CONCLUSION: Activation of Gq-coupled signalling has a major impact on impulse generation, impulse propagation, and coordinated impulse delivery in the heart. Thus, Gq-coupled signalling does not only modulate the myocytes' Ca2+ handling but also directly alters the heart's electrophysiological properties such as intercellular communication. This study greatly advances our understanding of the plethora of modulatory influences of Gq signalling on the heart in vivo. Published on behalf of the European Society of Cardiology. All rights reserved.
AIMS: Signalling via Gq-coupled receptors is of profound importance in many cardiac diseases such as hypertrophy and arrhythmia. Nevertheless, owing to their widespread expression and the inability to selectively stimulate such receptors in vivo, their relevance for cardiac function is not well understood. We here use DREADD technology to understand the role of Gq-coupled signalling in vivo in cardiac function. METHODS AND RESULTS: We generated a novel transgenic mouse line that expresses a Gq-coupled DREADD (Dq) in striated muscle under the control of the muscle creatine kinase promotor. In vivo injection of the DREADD agonist clozapine-N-oxide (CNO) resulted in a dose-dependent, rapid mortality of the animals. In vivo electrocardiogram data revealed severe cardiac arrhythmias including lack of P waves, atrioventricular block, and ventricular tachycardia. Following Dq activation, electrophysiological malfunction of the heart could be recapitulated in the isolated heart ex vivo. Individual ventricular and atrial myocytes displayed a positive inotropic response and arrhythmogenic events in the absence of altered action potentials. Ventricular tissue sections revealed a strong co-localization of Dq with the principal cardiac connexin CX43. Western blot analysis with phosphor-specific antibodies revealed strong phosphorylation of a PKC-dependent CX43 phosphorylation site following CNO application in vivo. CONCLUSION: Activation of Gq-coupled signalling has a major impact on impulse generation, impulse propagation, and coordinated impulse delivery in the heart. Thus, Gq-coupled signalling does not only modulate the myocytes' Ca2+ handling but also directly alters the heart's electrophysiological properties such as intercellular communication. This study greatly advances our understanding of the plethora of modulatory influences of Gq signalling on the heart in vivo. Published on behalf of the European Society of Cardiology. All rights reserved.
Authors: Blaine N Armbruster; Xiang Li; Mark H Pausch; Stefan Herlitze; Bryan L Roth Journal: Proc Natl Acad Sci U S A Date: 2007-03-02 Impact factor: 11.205
Authors: N Wettschureck; H Rütten; A Zywietz; D Gehring; T M Wilkie; J Chen; K R Chien; S Offermanns Journal: Nat Med Date: 2001-11 Impact factor: 53.440
Authors: Lauren Mackenzie; Martin D Bootman; Mika Laine; Michael J Berridge; Jan Thuring; Andrew Holmes; Wen-Hong Li; Peter Lipp Journal: J Physiol Date: 2002-06-01 Impact factor: 5.182
Authors: Alexandre Caron; Ryan P Reynolds; Carlos M Castorena; Natalie J Michael; Charlotte E Lee; Syann Lee; Rebecca Berdeaux; Philipp E Scherer; Joel K Elmquist Journal: Mol Metab Date: 2019-06-22 Impact factor: 7.422
Authors: Barbara Szeiffova Bacova; Jana Radosinska; Gerd Wallukat; Miroslav Barancik; Anne Wallukat; Vladimir Knezl; Matus Sykora; Ludovit Paulis; Narcis Tribulova Journal: Int J Mol Sci Date: 2020-01-14 Impact factor: 5.923